Breaking news

Gold’s Gleam: Caution Amid The Rally

Gold prices are surging, with the SPDR Gold Shares (GLD) fund up about 11% in 2025 and returns climbing roughly 42% over the past year. Gold futures, too, are on the rise—up around 10% year-to-date and 36% higher than last year. By contrast, the S&P 500 has barely moved in 2025, gaining only 1.5%, and has risen 17% over the past year.

Yet, as the allure of the precious metal intensifies, seasoned investors are urging restraint. Certified financial planner Lee Baker of Claris Financial Advisors recalls, “I didn’t get any calls from clients about gold a year ago. Now, I get them regularly.” He cites Warren Buffett’s timeless advice: “Be cautious when others are greedy, and be greedy when others are fearful.” Baker warns that while the current fervor is tempting, the typical investor should limit gold allocation to no more than 3% of a diversified portfolio—lest they fall into the classic trap of buying high and selling low.

Why are gold prices on the rise? The answer lies in its enduring reputation as a safe haven during turbulent times. Investors flock to gold amid uncertainty, with recent US sanctions against Russia acting as a turbocharger for returns. These sanctions have spurred central banks, particularly in China, to boost their gold purchases instead of U.S. Treasury bonds, aiming to safeguard their reserves from potential geopolitical strife. Moreover, many see gold as a hedge against inflation, even though the data supporting that view remains mixed.

Samir Samana, senior global market strategist at Wells Fargo Investment Institute, notes, “In times of real crisis, bonds have shone brighter than gold.” His perspective underscores that while gold may shine during periods of high uncertainty, its rally might be unsustainable without a prolonged crisis.

For investors, the takeaway is clear: while gold’s current surge offers attractive returns, caution is paramount. As the market faces potential headwinds, following Buffett’s contrarian wisdom may help avoid the pitfalls of an overheated market. In the world of investing, where timing is everything, it’s not just about chasing returns—it’s about staying disciplined when the herd runs wild.

EU Records €220.5 Billion Pharmaceutical Trade Surplus In 2025

The European Union secured a historic trade surplus in medicinal and pharmaceutical products in 2025, according to a report from Eurostat. Export figures reached €366.2 billion while imports totaled €145.7 billion, leading to a surplus of €220.5 billion.

Robust Growth In Exports And Imports

Exports increased by 16.0% from €315.7 billion in 2024. Imports rose by 21.0% from €120.4 billion over the same period. The data show continued expansion in trade volumes across the sector.

Leading National Performances

Ireland recorded the highest exports to non-EU countries at €93.8 billion. Germany and Belgium followed with €67.9 billion and €38.5 billion, respectively. Italy led imports at €27.5 billion, with Belgium and Germany also recording significant volumes.

Global Trade Partnerships

The United States was the largest destination for EU exports, accounting for 43.8% or €160.6 billion. Switzerland followed with 16.3% (€59.7 billion), while the United Kingdom accounted for 5.6% (€20.6 billion). On the import side, the United States supplied 41.2% of total imports (€60.1 billion), followed by Switzerland at 28.4% (€41.4 billion) and China at 9.0% (€13.1 billion).

Uol
eCredo
Aretilaw firm
The Future Forbes Realty Global Properties

Become a Speaker

Become a Speaker

Become a Partner

Subscribe for our weekly newsletter